Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 751-760 of 1772 for

Edit search filters
  1. Pembrolizumab Alone Or With Idelalisib Or Ibrutinib In Treating Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia Or Other Low-Grade B-Cell Non-Hodgkin Lymphomas

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. Radiation Therapy With Or Without Chemotherapy In Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery

    Rochester, MN

  3. Study To Assess The Effectiveness And Safety Of Ublituximab + TGR-1202 With Or Without Bendamustine And TGR-1202 Alone To Treat Patients With Previously Treated Non-Hodgkins Lymphoma

    Jacksonville, FL

  4. A Study Of Proton Versus Photon Beam Radiotherapy In The Treatment Of Unilateral Head And Neck Cancer

    Rochester, MN

  5. Testing The Addition Of Ixazomib To Lenalidomide In Patients With Evidence Of Residual Multiple Myeloma, OPTIMUM Trial

    La Crosse, WI, Rochester, MN

  6. A Study To Evaluate The Safety, Tolerability, And Determine The Optimal Dose For The Expansion Cohorts Of VSV-IFNβ-NIS In Combination With Pembrolizumab In Patients With Refractory Solid Tumors

    Rochester, MN

  7. A Study Of Neoadjuvant/Adjuvant Durvalumab For The Treatment Of Patients With Resectable Non-small Cell Lung Cancer (AEGEAN)

    Scottsdale/Phoenix, AZ

  8. A Study To Evaluate Treatment Of Established Chemotherapy-induced Neuropathy With Fingolimod

    Mankato, MN, Rochester, MN

  9. A Study To Evaluate The Safety And Effectiveness Of Idecabtagene Vicleucel To Treat Multiple Myeloma

    Jacksonville, FL, Rochester, MN

  10. Retifanlimab And Epacadostat In Combination With Radiation And Bevacizumab In Patients With Recurrent Gliomas

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer